We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
American Outdoor Brands
AOUT
$159M
| $1.12M | ﹤0.01% |
44,330
+30,728
| +226% | +$660K |
|
|
NVTA
1502
DELISTED
Invitae Corporation
NVTA
| $1.11M | ﹤0.01% |
29,171
-21,418
| -42% | -$974K |
|
1503
Goosehead Insurance
GSHD
$2.32B
| $1.11M | ﹤0.01% |
10,390
-899
| -8% | -$122K |
|
1504
Alexandria Real Estate Equities
ARE
$8.28B
| $1.11M | ﹤0.01% |
6,760
+626
| +10% | +$104K |
|
1505
SiTime
SITM
$20.1B
| $1.11M | ﹤0.01% |
+11,268
| New | +$1.32M |
|
1506
Extra Space Storage
EXR
$31B
| $1.11M | ﹤0.01% |
8,438
-1,010
| -11% | -$122K |
|
1507
National Bank Holdings
NBHC
$1.92B
| $1.11M | ﹤0.01% |
+27,900
| New | +$1.04M |
|
1508
NWPX Infrastructure Inc
NWPX
$1.08B
| $1.1M | ﹤0.01% |
33,055
-6,316
| -16% | -$205K |
|
1509
EastGroup Properties
EGP
$10.8B
| $1.1M | ﹤0.01% |
7,703
-5,377
| -41% | -$753K |
|
1510
Bank of N.T. Butterfield & Son
NTB
$2.49B
| $1.1M | ﹤0.01% |
28,888
-2,851
| -9% | -$101K |
|
1511
BridgeBio Pharma
BBIO
$16.4B
| $1.1M | ﹤0.01% |
17,890
+13,989
| +359% | +$915K |
|
1512
AdaptHealth
AHCO
$754M
| $1.1M | ﹤0.01% |
29,952
+16,495
| +123% | +$583K |
|
1513
Occidental Petroleum
OXY
$59B
| $1.1M | ﹤0.01% |
41,345
-65,742
| -61% | -$1.64M |
|
|
GDEN
1514
DELISTED
Golden Entertainment
GDEN
| $1.1M | ﹤0.01% |
43,492
+14,025
| +48% | +$315K |
|
|
IMGN
1515
DELISTED
Immunogen Inc
IMGN
| $1.1M | ﹤0.01% |
135,348
+44,932
| +50% | +$367K |
|
1516
Financial Institutions
FISI
$821M
| $1.09M | ﹤0.01% |
+35,974
| New | +$972K |
|
1517
Gibraltar Industries
ROCK
$1.48B
| $1.09M | ﹤0.01% |
11,888
-13,469
| -53% | -$1.24M |
|
1518
CBIZ
CBZ
$2.96B
| $1.09M | ﹤0.01% |
33,253
-6,380
| -16% | -$188K |
|
|
NAV
1519
DELISTED
Navistar International
NAV
| $1.08M | ﹤0.01% |
24,540
| – | – |
|
|
RP
1520
DELISTED
RealPage, Inc.
RP
| $1.07M | ﹤0.01% |
12,321
-30,150
| -71% | -$2.62M |
|
1521
Ocular Therapeutix
OCUL
$2.14B
| $1.07M | ﹤0.01% |
65,077
+16,291
| +33% | +$314K |
|
1522
Clean Energy Fuels
CLNE
$377M
| $1.06M | ﹤0.01% |
77,506
+56,902
| +276% | +$729K |
|
|
PRMW
1523
DELISTED
Primo Water Corporation
PRMW
| $1.06M | ﹤0.01% |
65,307
+4,493
| +7% | +$72.2K |
|
|
ARI
1524
Apollo Commercial Real Estate
ARI
$862M
| $1.06M | ﹤0.01% |
75,779
| – | – |
|
1525
Iovance Biotherapeutics
IOVA
$2.94B
| $1.06M | ﹤0.01% |
34,022
-5,077
| -13% | -$210K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.